| C026486 | 1,2,5,6-dibenzanthracene | "[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CLDN7 mRNA" | 18711122 |
| C026486 | 1,2,5,6-dibenzanthracene | "[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA" | 18711122 |
| C026486 | 1,2,5,6-dibenzanthracene | "[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CLDN7 mRNA" | 18711122 |
| C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in decreased expression of CLDN7 mRNA" | 23826121 |
| C006551 | 2-amino-2-methyl-1-propanol | 2-amino-2-methyl-1-propanol results in decreased expression of CLDN7 mRNA | 25088246 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CLDN7 mRNA | 29067470 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of CLDN7 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of CLDN7 mRNA | 22100608|2715375 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CLDN7 mRNA | 16483693 |
| C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of CLDN7 mRNA" | 22863853 |
| D001151 | Arsenic | Arsenic results in increased expression of CLDN7 mRNA | 24349408 |
| D001151 | Arsenic | Arsenic affects the localization of CLDN7 protein | 24349408 |
| C006632 | arsenic trioxide | CLDN7 protein results in decreased susceptibility to arsenic trioxide | 20707922 |
| C015001 | arsenite | arsenite results in decreased methylation of CLDN7 promoter | 23974009 |
| D001241 | Aspirin | Aspirin results in increased expression of CLDN7 mRNA | 12800193 |
| C487081 | belinostat | belinostat results in increased expression of CLDN7 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CLDN7 mRNA | 18164116 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CLDN7 mRNA | 22228805 |
| D001564 | Benzo(a)pyrene | "[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CLDN7 mRNA" | 18711122 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CLDN7 mRNA | 18711122 |
| D004958 | Estradiol | Estradiol affects the expression of CLDN7 mRNA | 15598610 |
| D004958 | Estradiol | Estradiol results in increased expression of CLDN7 mRNA | 14664709|1528915 |
| C095105 | bexarotene | bexarotene results in increased expression of CLDN7 mRNA | 16648578 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLDN7 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A affects the expression of CLDN7 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CLDN7 mRNA | 18180321 |
| C584509 | C646 compound | C646 compound results in increased expression of CLDN7 mRNA | 26191083 |
| C055494 | caffeic acid phenethyl ester | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CLDN7 mRNA | 20360939 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of CLDN7 mRNA | 25979313 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN7 mRNA | 20938992 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CLDN7 mRNA | 27989131 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CLDN7 mRNA | 21865292 |
| C014347 | decitabine | decitabine inhibits the reaction [Smoke results in decreased expression of CLDN7 mRNA] | 21095227 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLDN7 mRNA | 28628672 |
| C041517 | dibenzo(a,l)pyrene | "[1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CLDN7 mRNA" | 18711122 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of CLDN7 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CLDN7 mRNA | 27392435 |
| D002945 | Cisplatin | CLDN7 protein results in decreased susceptibility to Cisplatin | 21134740 |
| D004026 | Dieldrin | Dieldrin results in increased expression of CLDN7 mRNA | 20438755 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of CLDN7 mRNA | 25016146 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CLDN7 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CLDN7 mRNA | 18164116 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CLDN7 mRNA | 20360939 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CLDN7 mRNA | 25242112 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CLDN7 mRNA | 14664709|1528915 |
| D002117 | Calcitriol | Calcitriol results in increased expression of CLDN7 mRNA | 26485663 |
| C118739 | entinostat | entinostat results in increased expression of CLDN7 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CLDN7 mRNA | 22079256 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CLDN7 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN7 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CLDN7 mRNA | 15834898|1755790 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of CLDN7 mRNA | 18035473 |
| C007738 | fluoranthene | "[1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CLDN7 mRNA" | 18711122 |
| C007738 | fluoranthene | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of CLDN7 mRNA | 18711122 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CLDN7 mRNA | 17187413 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN7 mRNA | 20938992 |
| C039281 | furan | furan results in increased expression of CLDN7 mRNA | 27387713 |
| D019833 | Genistein | Genistein results in increased expression of CLDN7 mRNA | 15289156 |
| D017313 | Fenretinide | Fenretinide results in increased expression of CLDN7 mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of CLDN7 mRNA | 18661270 |
| C492448 | ICG 001 | ICG 001 results in increased expression of CLDN7 mRNA | 26191083 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLDN7 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CLDN7 mRNA | 28628672 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of CLDN7 mRNA | 27392435 |
| C544151 | jinfukang | jinfukang results in increased expression of CLDN7 mRNA | 27392435 |
| C045463 | leflunomide | leflunomide results in decreased expression of CLDN7 mRNA | 28988120 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of CLDN7 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLDN7 mRNA | 20938992 |
| D008727 | Methotrexate | Methotrexate results in increased expression of CLDN7 mRNA | 21678067 |
| D008727 | Methotrexate | Methotrexate affects the expression of CLDN7 mRNA | 18502557 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in decreased expression of CLDN7 mRNA | 16525678 |
| C523799 | MRK 003 | CLDN7 results in decreased susceptibility to MRK 003 | 19903844 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CLDN7 mRNA | 25102026 |
| D009532 | Nickel | Nickel results in decreased expression of CLDN7 mRNA | 25583101 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of CLDN7 mRNA | 26272509 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of CLDN7 mRNA | 26272509 |
| C014153 | pirimiphos methyl | pirimiphos methyl results in increased expression of CLDN7 mRNA | 27845199 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CLDN7 mRNA | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of CLDN7 mRNA | 12832660 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CLDN7 mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of CLDN7 mRNA | 22079256 |
| D011374 | Progesterone | Progesterone results in decreased expression of CLDN7 mRNA | 23018184 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of CLDN7 mRNA | 25895662 |
| D020123 | Sirolimus | Sirolimus results in increased expression of CLDN7 mRNA | 21865292 |
| D012906 | Smoke | decitabine inhibits the reaction [Smoke results in decreased expression of CLDN7 mRNA] | 21095227 |
| D012906 | Smoke | Smoke results in decreased expression of CLDN7 mRNA | 21095227 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CLDN7 mRNA | 24349408 |
| C017947 | sodium arsenite | sodium arsenite affects the localization of CLDN7 protein | 24349408 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of CLDN7 mRNA | 22561333 |
| D016559 | Tacrolimus | Tacrolimus results in increased expression of CLDN7 mRNA | 21865292 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CLDN7 mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CLDN7 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CLDN7 mRNA | 27913140 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of CLDN7 mRNA | 23411599 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of CLDN7 mRNA | 23409001 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of CLDN7 mRNA | 27404394 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CLDN7 mRNA | 16236135 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CLDN7 mRNA | 24935251|2627250 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CLDN7 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CLDN7 mRNA | 23179753|2352703 |
| D014640 | Vancomycin | Vancomycin results in decreased expression of CLDN7 mRNA | 18930951 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLDN7 mRNA" | 27188386 |